Delivery Order SPE2DB24D2003-SPE2DB25FXLS7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract value of $2,570.36 and a firm fixed price structure. This delivery order, valued at the ceiling amount specified, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The work is to be performed at the company's corporate office in Conshohocken, Pennsylvania, and the...
- The Defense Logistics Agency awarded a $1,154.87 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sunosi 150 mg tablets (30-count units). This competitive, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 13, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.77 to AmerisourceBergen Drug Corp for SUNOSI 150 mg tablets (30-count supply) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award involved no set-aside designation and was competitively awarded....
- The Defense Logistics Agency awarded a $1,817.13 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 tablets of Sunosi 150 mg, with an ultimate completion date of August 13, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,404.99 for 30 tablets of Sunosi 75 mg on August 1, 2025, with an ultimate completion date of August 4, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and represents a child award under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp received a delivery order valued at $4,627.82 from the Defense Logistics Agency (DLA) on July 22, 2025, for the supply of Sunosi 75 mg tablets (30-count units). This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by July 23, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Sunosi 150 mg tablets to the government. The firm-fixed-price delivery order, valued at $1,796.57, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 4, 2024 and was awarded on November 1, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- The Defense Logistics Agency awarded a $1,881.03 delivery order to AmerisourceBergen Drug Corp for Sunosi 75 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Sunosi 150 mg tablets in quantities of 30. The contract has a firm fixed-price of $1,981.97 and a performance period ending on July 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which enables the company to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,322.06, is for the delivery of Sunosi 75 mg tablets. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLS7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Sunosi 150 mg tablets (30-count units) with a contract ceiling value of $2,746.87. This is a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through competitive procurement. The contract is classified as a child award, meaning it derives from a larger indefinite delivery contract vehicle. Performance will be executed from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive pharmaceutical support vehicle enables the company to supply a wide range of medications and medical supplies to support Department of Defense healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of federal contracts covering various therapeutic domains, including specialty medications, brand-name and generic drugs, and medical devices for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/15/25 |